This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. The delivery order has a ceiling value of $1,831.88 and a performance period through April 11, 2024. This award is part of a larger indefinite delivery contract (IDC) held...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, and has a ceiling value of $3,248.94. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medical product. The contract has a ceiling value of $13,046.07 and an ultimate completion date of November 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a maximum potential value of $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $47,211.38, is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml to support federal healthcare programs. The contract has an ultimate completion date of March 12, 2024 and is a firm fixed price delivery order. This award is associated with a larger Indefinite Delivery Contract...
This is a $5,260.74 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and...
This is a $6,074.30 firm fixed-price delivery order awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML pharmaceutical products. The contract has an ultimate completion date of February 5, 2025 and was awarded on February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the Defense Logistics Agency Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,786.59, is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,202.09 and is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 17, 2024. It is not designated as a set-aside contract. AmerisourceBergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4557044485 - BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty pharmaceutical product. The award has a ceiling value of $16,259.59 and a period of performance through April 29, 2022. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with a ceiling value of $1,069.63 and a performance period through March 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a larger...